Clinical Trials Logo

Clinical Trial Summary

A parallel-group non-inferiority randomized controlled trial will then be conducted to evaluate the performance of HIVST-Chatbot. A total of 528 Hong Kong Chinese speaking men who have sex with men (MSM) aged ≥18 years who have access to live-chat applications are recruited from multiple sources. Those who are diagnosed as HIV positive are excluded. Participants are 1:1 randomized into the intervention group (n=264) or the control group (n=264). The research team will implement the HIVST-Chatbot (HIVST services with real-time counselling provided by a fully-automated artificial intelligence Chatbot) in the intervention group and HIVST-OIC (HIVST with real-time counselling provided by trained administrators) in the control group. Participants completed two telephone surveys at baseline and six months afterwards.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05796622
Study type Interventional
Source Chinese University of Hong Kong
Contact Zixin Wang, PhD
Phone +852 22528740
Email wangzx@cuhk.edu.hk
Status Not yet recruiting
Phase N/A
Start date April 16, 2023
Completion date February 28, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04026815 - Health Status and Its Socio-economic Covariates of the Older Population in Poland - the Nationwide PolSenior2 Survey.